Daisuke KUDO, Kazuteru OHASHI, Takuya KOMENO, Yuichi NAKAMURA,
Atsushi SHINAGAWA, Chikashi YOSHIDA, Yukitaka KATSURA, Ikuyo OTA, Kazuhiko KAKIHANA,
Takeshi KOBAYASHI, Nobutaka KAWAI, Atsushi KATO, Ayako ARAI, Koh YAMAMOTO,
Shigeo TOYOTA, Takashi KUMAGAI, Akira OHWADA, Toru MIKI, Mitsuo HORI,
Yasushi OKOSHI, Hiroshi KOJIMA and Hisashi SAKAMAKI;
on behalf of the Ochanomizu Hematology Study Group
Efficacy and safety of bortezomib-containing induction
chemotherapy for autologous stem cell transplantation-eligible
Japanese multiple myeloma patients
—A phase 2 multicenter trial—
International Journal of Myeloma 5(3): 15–22, 2015
Akinori NISHIKAWA, Shinobu TAMURA, Kazuo HATANAKA, Kodai KURIYAMA,
Hiroki HOSOI, Shogo MURATA, Nobuyoshi HANAOKA, Noboru YONETANI,
Toshiharu TAMAKI, Hideki NAKAKUMA and Takashi SONOKI
Outcome of allogeneic hematopoietic stem-cell transplantation for
multiple myeloma: retrospective analysis of 16 patients
International Journal of Myeloma 5(3): 23–29, 2015
|
